FDC informs about updates

23 Aug 2024 Evaluate
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, FDC has informed that U.S. Food and Drug Administration (FDA) had conducted an inspection at Company’s manufacturing facility located at Baddi, Himachal Pradesh which is dedicated for manufacturing Cephalosporin Oral dosage forms. The said audit has been successfully completed by the US FDA with ‘No observations’ (Zero 483’s).

The above information is a part of company’s filings submitted to BSE.

FDC Share Price

381.45 5.95 (1.58%)
22-Jan-2026 11:41 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1628.75
Dr. Reddys Lab 1220.10
Cipla 1379.95
Zydus Lifesciences 884.60
Lupin 2183.90
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×